Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
|Podcasts|January 6, 2022
Why women shouldn’t be discouraged to go into the field of urology
Author(s)Urology Times staff
It's the hidden gem in medicine,” says Efe Chantal Ghanney Simons, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Efe Chantal Ghanney Simons, MD. She discusses the struggles that come with being a woman in urology, but also highlights the need for more female urologists to diversify and expand the field. Ghanney Simons is a PGY5 urology resident physician at the University of California, Los Angeles.
Advertisement
Related to this article
Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
Advertisement
Advertisement
Trending on Urology Times
1
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
2
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
3
How PSMA-PET shapes staging and recurrence workup in prostate cancer
4
Michael Cookson, MD, reacts to Anktiva’s expanded approval in NMIBC
5